建立小肠腺癌的护理标准：挑战与经验教训。
Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learned.
机构信息
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
出版信息
Oncologist. 2012;17(9):1133-4. doi: 10.1634/theoncologist.2012-0323. Epub 2012 Aug 24.
Abstract
This commentary discusses the role of retrospective studies in the investigation of treatment options for small bowel adenocarcinoma.
摘要
本述评讨论了回顾性研究在探讨小肠腺癌治疗方案中的作用。
相似文献
1
Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learned.
Oncologist. 2012;17(9):1133-4. doi: 10.1634/theoncologist.2012-0323. Epub 2012 Aug 24.
2
Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine.
Leuk Lymphoma. 2007 May;48(5):1032-3. doi: 10.1080/10428190701216378.
3
[I. Chemotherapy for Small Bowel Adenocarcinoma].
Gan To Kagaku Ryoho. 2018 Nov;45(11):1589-1593.
4
What are the latest pharmacotherapy options for small bowel adenocarcinoma?
Expert Opin Pharmacother. 2014 Apr;15(6):745-8. doi: 10.1517/14656566.2014.891016. Epub 2014 Mar 4.
5
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
J Clin Oncol. 2009 Jun 1;27(16):2598-603. doi: 10.1200/JCO.2008.19.7145. Epub 2009 Jan 21.
6
Chemotherapy for primary adenocarcinoma of the small bowel.
Cancer. 1984 Jan 1;53(1):23-5. doi: 10.1002/1097-0142(19840101)53:1<23::aid-cncr2820530106>3.0.co;2-u.
7
Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
Int J Clin Oncol. 2020 Aug;25(8):1441-1449. doi: 10.1007/s10147-020-01703-z. Epub 2020 May 24.
8
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
Cancer. 2017 May 15;123(6):1011-1017. doi: 10.1002/cncr.30445. Epub 2016 Nov 14.
9
Management of small bowel adenocarcinoma: making the most of the available evidence to inform routine practice.
Curr Opin Oncol. 2021 Jul 1;33(4):368-371. doi: 10.1097/CCO.0000000000000747.
10
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Cancer. 2011 Apr 1;117(7):1422-8. doi: 10.1002/cncr.25614. Epub 2010 Nov 8.
本文引用的文献
1
Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy.
Oncologist. 2012;17(9):1163-70. doi: 10.1634/theoncologist.2012-0079. Epub 2012 May 23.
2
A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma.
Anticancer Drugs. 2012 Jun;23(5):561-6. doi: 10.1097/CAD.0b013e328350dd0d.
3
A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease.
Ann Surg Oncol. 2012 May;19(5):1439-45. doi: 10.1245/s10434-011-2173-6. Epub 2011 Dec 21.
4
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers.
Ann Oncol. 2012 Feb;23(2):367-74. doi: 10.1093/annonc/mdr122. Epub 2011 May 17.
5
Crohn's disease and small bowel adenocarcinoma: a population-based case-control study.
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1120-3. doi: 10.1158/1055-9965.EPI-10-1281. Epub 2011 Apr 5.
6
Cetuximab in small bowel adenocarcinoma: a new friend?
Br J Cancer. 2010 Oct 12;103(8):1305; author reply 1306. doi: 10.1038/sj.bjc.6605898. Epub 2010 Sep 14.
7
A single-institution experience with 491 cases of small bowel adenocarcinoma.
Am J Surg. 2010 Jun;199(6):797-803. doi: 10.1016/j.amjsurg.2009.05.037.
8
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.
Ann Oncol. 2010 Sep;21(9):1786-1793. doi: 10.1093/annonc/mdq038. Epub 2010 Mar 11.
9
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.
Br J Cancer. 2010 Jan 5;102(1):144-50. doi: 10.1038/sj.bjc.6605449. Epub 2009 Nov 24.
10
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
J Clin Oncol. 2009 Jun 1;27(16):2598-603. doi: 10.1200/JCO.2008.19.7145. Epub 2009 Jan 21.
Zotero 插件